Checkpoint inhibitor therapies are a form of immunotherapy used to treat cancer by leveraging the body's immune system. These therapies work by blocking proteins called checkpoints, which are used by cancer cells to evade the immune system. By inhibiting these checkpoints, immune cells such as T-cells can effectively target and destroy cancer cells.
